BLOOD CANCER
Clinical trials for BLOOD CANCER explained in plain language.
Never miss a new study
Get alerted when new BLOOD CANCER trials appear
Sign up with your email to follow new studies for BLOOD CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to wipe out lingering leukemia cells before they return
Disease control Recruiting nowThis study tests whether a new combination of three drugs (tagraxofusp, azacitidine, and venetoclax) can safely eliminate leftover leukemia cells that are not visible under a microscope in adults with acute myeloid leukemia (AML). These hidden cells can cause the cancer to come b…
Matched conditions: BLOOD CANCER
Phase: PHASE1, PHASE2 • Sponsor: Jacqueline Garcia, MD • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Supercharging immune cells to fight blood cancer
Disease control Recruiting nowThis study tests a new treatment for people with certain blood cancers, like leukemia. Doctors take a patient's own immune cells, modify them in a lab to recognize unique markers on their cancer cells, and then give them back. The goal is to see if this personalized therapy is sa…
Matched conditions: BLOOD CANCER
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Gene-Guided dosing aims to stop deadly fungal infections in cancer patients
Disease control Recruiting nowThis study tests whether using a patient's genetic information to dose the antifungal drug voriconazole can help more patients reach the right drug level in their blood compared to standard dosing. The trial will enroll about 104 children and adults with blood cancer or fungal in…
Matched conditions: BLOOD CANCER
Phase: PHASE2 • Sponsor: The University of Queensland • Aim: Disease control
Last updated May 04, 2026 16:19 UTC
-
New study tests palliative care for blood cancer patients on advanced cell therapy
Symptom relief Recruiting nowThis study looks at whether adding a special palliative care program (called PEACE) to usual cancer care can help adults with lymphoma, leukemia, or multiple myeloma who are receiving cell therapy. About 90 participants will be randomly assigned to either get PEACE plus standard …
Matched conditions: BLOOD CANCER
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 17, 2026 00:48 UTC
-
Exercise may improve sleep for young cancer patients
Symptom relief Recruiting nowThis study looks at whether doing light, adapted physical activity every day can improve sleep in children aged 5 to 16 who are being treated for blood cancer. Researchers will track sleep quality, night awakenings, and overall well-being in 30 participants. The goal is to find a…
Matched conditions: BLOOD CANCER
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
New biomarkers could personalize treatment for deadly transplant complication
Knowledge-focused Recruiting nowThis study looks for biological markers (biomarkers) in the blood or stool that can help doctors predict how severe gut graft-versus-host disease (GvHD) will become and whether a patient will respond to treatment. GvHD is a serious complication that can occur after a stem cell tr…
Matched conditions: BLOOD CANCER
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC
-
Blood test may predict immunotherapy success in cancer patients
Knowledge-focused Recruiting nowThis study is for people with cancer who are about to start or have already received FDA-approved immunotherapy. Researchers want to see if special blood tests (immune-methylation and cytokine profiling) can predict whether the treatment will work. The goal is to better understan…
Matched conditions: BLOOD CANCER
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Knowledge-focused
Last updated May 05, 2026 11:54 UTC